Bioresorbable scaffolds are naturally dissolving devices which are innovated from traditional scaffolds. It is also known as naturally dissolving stentsor bioresorbable stents. These devices are used for prevention or treatment of blockage in blood vessels. Some of the other benefits are includes the better patient outcomes, greater patient compliance, ability of treatment to encourage blood vessels to regain vasomotor functionality and lesser requirements for anti-platelet therapy & administration of anti-thrombotic drugs.
According to study, “Global Bioresorbable Scaffolds Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024” some of the major factors which are currently working in the global bioresorbable scaffolds market are AbbottVascular, REVA Medical Inc., Kyoto Medical Planning Co. Ltd., B. Braun, Xenogenics Corp., Amaranth Medical, Inc., Meril Life Sciences Pvt. Ltd., Arterial Remodeling Technologies,LEPU medical technology co., ltd., Arterius Limited, Boston Scientific Corporation, Elixir Medical Corp.,480 Biomedical, ORBUSNEICH, Qualimed, S3V Vascular Technologies Private Limited, Biotronik. International players are progressively expanding their footprint in developing economy, making it complicated for regional vendors to compete with them, especially for instance product differentiation, quality, product portfolios, and pricing.
Based on type, global bioresorbable scaffolds market is segmented into polymer based bioresorbable scaffolds and metal base bioresorbable scaffolds. Metal base bioresorbable scaffolds include iron, zinc, magnesium, and their alloys. Based on material, market is bifurcated into absorbable magnesium stent (AMS), poly carbonate scaffold, polymeric scaffold and others. Based on devices type, market is classified as drug eluting coronary scaffolds, sirolimus-eluting device, everolimus-eluting device, novolimus-eluting device and paclitaxel-eluting device. Based on absorption rate, market is breakdown into slow absorption rate and fast absorption rate. Based on application, market is segmented into regulation of blood flow, peripheral vascular intervention and others. In addition, based on end-users, market is defined as clinics, hospitals, medical center and others.
The global bioresorbable scaffolds market is driven by increase in prevalence of cardiovascular disease & diabetes, followed by rapid development in devices used for the cardiovascular surgeries, highly unhealthy lifestyles choices for instance poor diet and sedentary lifestyles adoption of desk-bound lifestyle, rising demand for bioresorbable scaffolds and government support for the research and development (R&D) of better medical devices. However, high cost of the bioresorbable scaffolds and availability of alternative therapies that are expected to restrain the market growth.
The global bioresorbable scaffolds market is dominated by North-American region due to presence of number of leading companies, and presence of large population suffering from cardiovascular diseases, with the increased geriatric population. Moreover, increase in obese & diabetic population, increasing stress,lack of exercise and desk-bound lifestyle has further provided thrust to the growth of market followed by North-America, Europe to remain the other key market owing to increase in government support and availability of huge research funds. Furthermore, Asia Pacific region accounted for substantial growth of market owing to increase in healthcare industry, rapid development in technology, and huge patient sufferings. On the other hand, the Middle East & Africa holds least share in caused by the presence of poor economies within the African region.In 2019, value of global bioresorbable scaffolds market is expected to reach at US $140 million and is estimated to reach at US $370 million, by 2024.
To know more, click on the link below:-
Ankur Gupta, Head Marketing & Communications